Racial and ethnic differences in treatment and survival among adults with primary extremity soft-tissue sarcoma

Cancer

Volumn 112, Issue 5, 2008, Pages 1162-1168

  Martinez, Steve R ^a   Robbins, Anthony S ^b   Meyers, Frederick J ^a   Bold, Richard J ^a   Khatri, Vijay P ^a   Goodnight Jr , James E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b PUBLIC HEALTH INSTITUTE   (United States)

Author keywords

Amputation; Disparities; Ethnicity; Extremity; Limb sparing; Race; Radiation; Sarcoma; Soft tissue

Indexed keywords

ADULT; AFRICAN AMERICAN; AGE; ARTICLE; ASIAN; CANCER EPIDEMIOLOGY; CANCER GRADING; CANCER MODEL; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER RISK; CANCER SURGERY; CANCER SURVIVAL; CANCER THERAPY; COMPARATIVE STUDY; CONFIDENCE INTERVAL; DATA BASE; DEMOGRAPHY; DISEASE COURSE; ETHNIC DIFFERENCE; EUROPEAN AMERICAN; FEMALE; HAZARD RATIO; HISPANIC; HISTOLOGY; HUMAN; LIMB AMPUTATION; LIMB TUMOR; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RACE DIFFERENCE; SEX; SOFT TISSUE SARCOMA; TUMOR VOLUME;

AFRICAN CONTINENTAL ANCESTRY GROUP; AMPUTATION; ASIAN CONTINENTAL ANCESTRY GROUP; ETHNIC GROUPS; EUROPEAN CONTINENTAL ANCESTRY GROUP; EXTREMITIES; HEALTHCARE DISPARITIES; HISPANIC AMERICANS; HUMANS; MALE; MIDDLE AGED; RADIOTHERAPY, ADJUVANT; SARCOMA; SOCIOECONOMIC FACTORS; SURVIVAL RATE;

EID: 39749200137     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.23261     Document Type: Article

References (36)

1. American Cancer Society. Cancer Facts and Figures 2007. Atlanta, Ga: American Cancer Society; 2007.
2. Brennan M, Singer S, Maki RG, et al. Sarcomas of the soft tissues and bone. In: DeVita VT Jr, Hellman S, Rosenberg SA, eds. Cancer: Principles and Practice of Oncology, 7th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2005.
3. Consensus Conference. Limb-sparing treatment of adult soft-tissue sarcomas and osteosarcomas. JANIA. 1985;254:1791-1794.
4. Pisters PW, O'Sullivan B, Maki RG. Evidence-based recommendations for local therapy for soft tissue sarcomas. J Clin Oncol. 2007;25:1003-1008.
5. Brennan MF, Casper ES, Harrison LB, Shiu MH, Gaynor J, Hajdu SI. The role of multimodality therapy in soft-tissue sarcoma. Ann Surg. 1991;214:328-336; discussion 336-338.
6. Yang JC, Chang AE, Baker AR, et al. Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity. J Clin Oncol. 1998;16:197-203.
7. O'Sullivan B, Davis AM, Turcotte R, et al. Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial. Lancet. 2002;359:2235-2241.
8. Pisters PW, Harrison LB, Leung DH, Woodruff JM, Casper ES, Brennan MF. Long-term results of a prospective randomized trial of adjuvant brachytherapy in soft tissue sarcoma. J Clin Oncol. 1996;14:859-868.
9. Mack TM. Sarcomas and other malignancies of soft tissue, retroperitoneum, peritoneum, pleura, heart, mediastinum, and spleen. Cancer. 1995;75(1 suppl):211-244.
10. Meric F, Hess KR, Varma DG, et al. Radiographic response to neoadjuvant chemotherapy is a predictor of local control and survival in soft tissue sarcomas. Cancer. 2002;95:1120-1126.
11. Temple CL, Ross DC, Magi E, DiFrancesco LM, Kurien E, Temple WJ. Preoperative chemoradiation and flap reconstruction provide high local control and low wound complication rates for patients undergoing limb salvage surgery for upper extremity tumors. J Surg Oncol. 2007;95:135-141.
12. Briggs NC, Levine RS, Hall HI, Cosby O, Brann EA, Hennekens CH. Occupational risk factors for selected cancers among African American and white men in the United States. Am J Public Health. 2003;93:1748-1752.
13. Brooks SE, Zhan M, Cote T, Baquet CR. Surveillance, Epidemiology, and End Results analysis of 2677 cases of uterine sarcoma 1989-1999. Gynecol Oncol. 2004;93:204-208.
14. Devesa SS, Blot WJ, Stone BJ, Miller BA, Tarone RE, Fraumeni JF Jr. Recent cancer trends in the United States. J Natl Cancer Inst. 1995;87:175-182.
15. Martinez SR, Chen SL, Bilchik AJ. Treatment disparities in Hispanic rectal cancer patients: a SEER database study. Am Surg. 2006;72:906-908.
16. O'Connell JB, Maggard MA, Ko CY. Cancer-directed surgery for localized disease: decreased use in the elderly. Ann Surg Oncol. 2004;11:962-969.
17. Sherman ME, Devesa SS. Analysis of racial differences in incidence, survival, and mortality for malignant tumors of the uterine corpus. Cancer. 2003;98:176-186.
18. Alderman AK, Kim HM, Kotsis SV, Chung KC. Upper-extremity sarcomas in the United States: analysis of the surveillance, epidemiology, and end results database, 1973-1998. J Hand Surg [Am]. 2003;28:511-518.
19. Marubini E, Valsecchi MG. Analysing Survival Data from Clinical Trials and Observational Studies. Chichester, England: John Wiley & Sons; 1995.
20. Racial and Ethnic Minorities. National Healthcare Disparities Report, 2005. Rockville, MD: US Department of Health and Human Services, Agency for Healthcare Research and Quality; 2005:119-130.
21. Gansler T, Henley SJ, Stein K, Nehl EJ, Smigal C, Slaughter E. Sociodemographic determinants of cancer treatment health literacy. Cancer. 2005;104:653-660.
22. Potosky AL, Harlan LC, Kaplan RS, Johnson KA, Lynch CF. Age, sex, and racial differences in the use of standard adjuvant therapy for colorectal cancer. J Clin Oncol. 2002;20:1192-1202.
23. Zahm SH, Fraumeni JF Jr. The epidemiology of soft tissue sarcoma. Semin Oncol. 1997;24:504-514.
24. Liu JH, Zingmond DS, McGory ML, et al. Disparities in the utilization of high-volume hospitals for complex surgery. JAMA. 2006;296:1973-1980.
25. Geer RJ, Woodruff J, Casper ES, Brennan MF. Management of small soft-tissue sarcoma of the extremity in adults. Arch Surg. 1992;127:1285-1289.
26. Kattan MW, Leung DH, Brennan MF. Postoperative nomogram for 12-year sarcoma-specific death. J Clin Oncol. 2002;20:791-796.
27. Smith SC Jr, Clark LT, Cooper RS, et al. Discovering the full spectrum of cardiovascular disease: Minority Health Summit 2003: report of the Obesity, Metabolic Syndrome, and Hypertension Writing Group. Circulation. 2005;111:e134-e139.
28. Suit HD, Spiro I. Role of radiation in the management of adult patients with sarcoma of soft tissue. Semin Surg Oncol. 1994;10:347-356.
29. Wilson AN, Davis A, Bell RS, et al. Local control of soft tissue sarcoma of the extremity: the experience of a multidisciplinary sarcoma group with definitive surgery and radiotherapy. Eur J Cancer. 1994;30A:746-751.
30. Barkley HT Jr, Martin RG, Romsdahl MM, Lindberg R, Zagars GK. Treatment of soft tissue sarcomas by preoperative irradiation and conservative surgical resection. Int J Radiat Oncol Biol Phys. 1988;14:693-699.
31. Rosenberg SA, Tepper J, Glatstein E, The treatment of soft-tissue sarcomas of the extremities: prospective randomized evaluations of limb-sparing surgery plus radiation therapy compared with amputation and the role of adjuvant chemotherapy. Ann Surg. 1982;196:305-315.
32. McGory ML, Zingmond DS, Sekeris E, Bastani R, Ko CY. A patient's race/ethnicity does not explain the underuse of appropriate adjuvant therapy in colorectal cancer. Dis Colon Rectum. 2006;49:319-329.
33. [No authors listed] Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: meta-analysis of individual data. Sarcoma Meta-analysis Collaboration. Lancet. 1997;350:1647-1654.
34. Frustaci S, Gherlinzoni F, De Paoli A, et al. Adjuvant chemotherapy for adult soft tissue sarcomas of the extremities and girdles: results of the Italian randomized cooperative trial. J Clin Oncol. 2001;19:1238-1247.
35. Tierney JF, Mosseri V, Stewart LA, Souhami RL, Parmar MK. Adjuvant chemotherapy for soft-tissue sarcoma: review and meta-analysis of the published results of randomised clinical trials. Br J Cancer. 1995;72:469-475.
36. Asch DA, Armstrong K. Aggregating and partitioning populations in health care disparities research: differences in perspective. J Clin Oncol. 2007;25:2117-2121.